BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, January 10, 2026
See today's BioWorld
Home
» Fund Pressures Actelion to Put Up a For-Sale Sign
To read the full story,
subscribe
or
sign in
.
Fund Pressures Actelion to Put Up a For-Sale Sign
Feb. 9, 2011
By
Nuala Moran
LONDON – The board of Actelion was forced to defend CEO Jean-Paul Clozel and deny it has received any offer to buy the company, following a demand from the U.S. hedge fund investor Elliott Advisors that it look for potential acquirers.
BioWorld